Oleic Acid

Oleic Acid

SCHEMBL2227151

CCCCCCCC/C=C\CCCCCCCC(=O)O.NCO

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.85
▸ PPARD Q03181 5/20 0.85
▸ PPARA Q07869 5/20 0.85
▸ F7 P08709 5/20 0.85
▸ F3 P13726 5/20 0.85
▸ TERT O14746 3/20 0.85
▸ PTPN1 P18031 3/20 0.85
▸ HSD17B10 Q99714 3/20 0.85
▸ FABP4 P15090 3/20 0.85
▸ TOP1 P11387 3/20 0.85
▸ MAPT P10636 2/20 0.85
▸ BLM P54132 2/20 0.85
▸ LMNA P02545 2/20 0.85
▸ ALOX15 P16050 2/20 0.85
▸ DUSP3 P51452 2/20 0.85
▸ CYP19A1 P11511 2/20 0.85
▸ PTGS1 P23219 2/20 0.85
▸ NR4A2 P43354 2/20 0.85
▸ SIRT6 Q8N6T7 2/20 0.85
▸ PTPN7 P35236 2/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleic Acid SCHEMBL5081237 0.96 PPARG (0.85) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL9418623 0.96 PPARG (0.85) PPARGPPARDPPARAF7F3
Erucic Acid SCHEMBL28182421 0.96 PPARG (0.85) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL4887835 0.94 PPARG (0.89) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL4887825 0.94 PPARG (0.89) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL146091 0.93 PPARG (0.79) PPARGPPARDPPARAF7F3
Elaidic Acid SCHEMBL21522133 0.93 PPARG (0.79) PPARGPPARDPPARAF7F3
Erucic Acid SCHEMBL6561087 0.92 PPARG (0.92) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL3751821 0.92 PPARG (0.92) PPARGPPARDPPARAF7F3
Nervonic Acid SCHEMBL27652694 0.92 PPARG (0.92) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3220934-B1 BIOLOGICALLY-ACTIVE TOMATO COMPOSITION HAVING REDUCED AMOUNT OF LYCOPENE LYCORED LTD (IL) 2019-06-12 — — EP disclosed
US-20170354704-A1 BIOLOGICALLY-ACTIVE TOMATO COMPOSITION HAVING REDUCED AMOUNT OF LYCOPENE LYCORED LTD. (IL) 2017-12-14 — — US disclosed
EP-3220934-A1 BIOLOGICALLY-ACTIVE TOMATO COMPOSITION HAVING REDUCED AMOUNT OF LYCOPENE Lycored Ltd. (IL) 2017-09-27 — — EP disclosed
WO-2016084068-A1 BIOLOGICALLY-ACTIVE TOMATO COMPOSITION HAVING REDUCED AMOUNT OF LYCOPENE LYCORED LTD. (IL) 2016-06-02 — — WO disclosed
EP-2516343-A2 METHOD OF MANUFACTURING WATER-RESISTANT GYPSUM ARTICLES AND ARTICLES FORMED THEREBY Georgia-Pacific Gypsum LLC (US) 2012-10-31 — — EP disclosed
WO-2011087781-A2 METHOD OF MANUFACTURING WATER-RESISTANT GYPSUM ARTICLES AND ARTICLES FORMED THEREBY GEORGIA-PACIFIC GYPSUM LLC (US) 2011-07-21 — — WO disclosed
EP-2167060-A1 SYNERGISTIC COMBINATIONS FOR TREATING HYPERTENSION Lycored Ltd. (IL) 2010-03-31 — — EP disclosed
EP-2043669-A2 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING GASTRO ESOPHAGEAL REFLUX DISEASE Lycored Ltd. (IL) 2009-04-08 — — EP disclosed
WO-2009007975-A1 SYNERGISTIC COMBINATIONS FOR TREATING HYPERTENSION LYCORED LTD (IL) 2009-01-15 — — WO disclosed
EP-1937240-A2 COMPOSITIONS FOR TREATMENT OF EYE DISEASES Lycored Ltd. (IL) 2008-07-02 — — EP disclosed
WO-2008001360-A2 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING GASTRO ESOPHAGEAL REFLUX DISEASE LYCORED LTD. (IL) 2008-01-03 — — WO disclosed
WO-2007096886-A2 COMPOSITION AND METHODS FOR TREATING AND PREVENTING AGE-RELATED MACULAR DEGENERATION LYCORED LTD. (IL) 2007-08-30 — — WO disclosed
WO-2007046083-A2 COMPOSITIONS FOR TREATMENT OF EYE DISEASES LYCORED LTD. (IL) 2007-04-26 — — WO disclosed
Send feedback